Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Open Angle Glaucoma or Ocular Hypertension”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03844945
What this trial is testing

Efficacy and Systemic Safety of Netarsudil 0.01%, 0.02%, 0.04% Relative to Placebo in Subjects With Open-angle Glaucoma or Ocular Hypertension in Japan

Who this might be right for
Open Angle GlaucomaOcular Hypertension
Aerie Pharmaceuticals 215
Large-scale testing (Phase 3)Study completedNCT01342081
What this trial is testing

DE-111 Against Tafluprost Ophthalmic Solution 0.0015% Alone and Concomitant Use of Tafluprost Ophthalmic Solution 0.0015% Plus Timolol Ophthalmic Solution 0.5%

Who this might be right for
Open Angle GlaucomaOcular Hypertension
Santen Pharmaceutical Co., Ltd. 489
Large-scale testing (Phase 3)Study completedNCT00546286
What this trial is testing

Evaluate the Effectiveness of Cosopt® as First Line Therapy (MK-0507A-153)

Who this might be right for
GlaucomaOcular Hypertension
Merck Sharp & Dohme LLC 170
Large-scale testing (Phase 3)Study completedNCT02278614
What this trial is testing

Efficacy and Safety Assessment of T2347 Versus Xalacom® in Ocular Hypertensive or Glaucomatous Patients

Who this might be right for
Open Angle GlaucomaOcular Hypertension
Laboratoires Thea 242
Early research (Phase 1)Study completedNCT01845038
What this trial is testing

Multi-Arm Feasibility Study Evaluating OTX-TP Compared to Timolol in Treatment of Subjects With Open Angle Glaucoma

Who this might be right for
Glaucoma
Ocular Therapeutix, Inc. 41
Large-scale testing (Phase 3)Study completedNCT01254604
What this trial is testing

Preservative-Free Tafluprost (MK-2452) for the Treatment of Open-Angle Glaucoma or Ocular Hypertension (MK-2452-002)

Who this might be right for
GlaucomaOcular Hypertension
Merck Sharp & Dohme LLC 190
Large-scale testing (Phase 3)Active Not RecruitingNCT06666855
What this trial is testing

A Phase III Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension in China

Who this might be right for
Open Angle GlaucomaOcular Hypertension
Santen Pharmaceutical Co., Ltd. 345
Testing effectiveness (Phase 2)Study completedNCT02743780
What this trial is testing

A Three Part Study of MGV354 in Ocular Hypertension or Glaucoma

Who this might be right for
Ocular HypertensionOpen-Angle Glaucoma
Alcon Research 191
Large-scale testing (Phase 3)Study completedNCT00751127
What this trial is testing

A 6 Month Study Comparing Latanoprost With Timolol in Patients With Open Angle Glaucoma or Ocular Hypertension

Who this might be right for
GlaucomaOpen Angle GlaucomaOcular Hypertension
Pfizer 268
Not applicableStudy completedNCT03931317
What this trial is testing

Study Comparing the Effects of Latanoprostene Bunod and Timolol on Retinal Blood Vessel Density and Visual Acuity

Who this might be right for
OAG - Open-Angle GlaucomaOHT - Ocular Hypertension
University of California, San Diego 70
Not applicableLooking for participantsNCT07390890
What this trial is testing

DSLT for Reducing Medication in Glaucoma

Who this might be right for
Primary Open Angle GlaucomaOcular Hypertension
The Eye Institute of West Florida 60
Testing effectiveness (Phase 2)Study completedNCT03657797
What this trial is testing

Phase 2 Dose-Response Study Evaluating the Safety and Efficacy of NCX 470 vs Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension

Who this might be right for
Glaucoma, Open-AngleHypertension, Ocular
Nicox Ophthalmics, Inc. 656
Not applicableStudy completedNCT01637246
What this trial is testing

Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Were Insufficiently Responsive to Monotherapy

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Allergan 4,385
Not applicableStudy completedNCT02348476
What this trial is testing

Simbrinza™ Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension

Who this might be right for
Open-Angle GlaucomaOcular Hypertension
Allergan 150
Testing effectiveness (Phase 2)Study completedNCT00845299
What this trial is testing

Study of the Effects of Artificial Tears on the Response to the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma

Who this might be right for
GlaucomaOcular Hypertension
Mati Therapeutics Inc. 40
Large-scale testing (Phase 3)Study completedNCT02059278
What this trial is testing

Safety and Efficacy of T-2345 Compared to Xalatan in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension

Who this might be right for
Primary Open Angle GlaucomaOcular Hypertension
Nephron Pharmaceuticals Corporation 335
Not applicableUnknownNCT01639807
What this trial is testing

Clinical Evaluation of Efficacy of SLT to Topical Medication in Lowering IOP

Who this might be right for
Glaucoma
Aurolab 600
Large-scale testing (Phase 3)Study completedNCT05583474
What this trial is testing

OPC-1085EL in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension in Chinese Subjects

Who this might be right for
Open Angle Glaucoma or Ocular Hypertension
Otsuka Beijing Research Institute 204
Testing effectiveness (Phase 2)Study completedNCT01936389
What this trial is testing

A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma

Who this might be right for
Exfoliation SyndromeOcular HypertensionOpen Angle Glaucoma
Robert Ritch, MD, LLC. 10
Early research (Phase 1)Study completedNCT00515424
What this trial is testing

Tolerability, Safety and Efficacy of RKI983 Eye Drops in Subjects With Primary Open Angle Glaucoma and Ocular Hypertension

Who this might be right for
GlaucomaOcular Hypertension
Novartis 90
Next Page